Why healthcare startups are struggling

With healthcare being the largest employer in the U.S. and projected to reach 20% of national GDP in the coming years, the sector is ripe with startups looking to make a stake. However, digital health startups are struggling, even with an influx of investment cash, as a result of the current market, according to Justin Barad, MD, co-founder of surgical training platform Osso VR.

Barad penned an article for TechCrunch on the market struggles healthcare startups currently face.

Part of the problem may be that tech companies are dipping their toes into healthcare using the tradition tech model: producing a product then finding uses for it. The same formula doesn’t work out in the more complex world of healthcare. Instead, the healthcare sector is more rewarding of needs-based innovations, according to Barad.

Despite this approach, the current ecosystem has “stunted” innovation, Barad argued, who laid out two “crushing challenges” to healthcare startups:

Institutional policies and hierarchical systems that maximize ownership and returns over innovation

Early-stage tech companies are misunderstood by the healthcare industry

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.